Literature DB >> 2542390

Partially compensated hypoadrenalism presenting with persistent skin pigmentation.

E M Whitehead1, A B Atkinson, D R Hadden, J Weaver, B Sheridan.   

Abstract

A 33-year-old female presented in 1966 with striking pigmentation, typical of Addison's disease, and amenorrhea. Endocrine assessment then showed normal basal serum cortisol and urinary hydroxysteroid levels, but serum cortisol did not respond to stimulation with either exogenous ACTH or lysine vasopressin. Steroid replacement treatment was started. Treatment was discontinued by the patient on her own initiative and after some yr she was lost to follow-up. Reassessment in 1986 showed a pigmented patient who had continued in good health. She had a normal basal serum cortisol level with circadian variation. Plasma ACTH levels were high but showed diurnal rhythmicity and suppressed incompletely with 2 mg or 8 mg of dexamethasone/24 h. Plasma aldosterone levels were normal and showed appropriate postural changes, but plasma renin levels were high. This patient has an immunological profile of autoimmune disease with positive adrenal, thyroid microsomal and gastric parietal cell antibodies with a history of a premature menopause which may also be of autoimmune origin. She has been seen over a 20-yr period and despite her appearance still has no biochemical evidence of glucocorticoid or mineralocorticoid deficiency. It is suggested that the patient had compensated hypoadrenalism, with serum cortisol levels maintained in the normal range by high plasma ACTH levels and serum aldosterone levels maintained by high renin levels. The long term result of the high ACTH levels was increased skin pigmentation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542390     DOI: 10.1007/BF03349957

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

1.  The use of intravenous ACTH: a study in quantitative adrenocortical stimulation.

Authors:  A E RENOLD; D JENKINS; P H FORSHAM; G W THORN
Journal:  J Clin Endocrinol Metab       Date:  1952-07       Impact factor: 5.958

2.  Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling.

Authors:  E H Oldfield; G P Chrousos; H M Schulte; M Schaaf; P E McKeever; A G Krudy; G B Cutler; D L Loriaux; J L Doppman
Journal:  N Engl J Med       Date:  1985-01-10       Impact factor: 91.245

3.  A possible ACTH secreting tumour of the pituitary developing in a conventionally treated case of Addison's disease.

Authors:  R L Himsworth; J G Lewis; L H Rees
Journal:  Clin Endocrinol (Oxf)       Date:  1978-08       Impact factor: 3.478

4.  Sella turcica enlargement and primary adrenal insufficiency.

Authors:  R G Dluhy; T J Moore; G H Williams
Journal:  Ann Intern Med       Date:  1978-10       Impact factor: 25.391

Review 5.  Adrenocortical insufficiency.

Authors:  C W Burke
Journal:  Clin Endocrinol Metab       Date:  1985-11

6.  Probable pituitary adenoma with adrenocorticotropin hypersecretion (corticotropinoma) secondary to Addison's disease.

Authors:  A Jara-Albarran; J Bayort; A Caballero; J Portillo; L Laborda; M Sampedro; C Cure; J M Mateos
Journal:  J Clin Endocrinol Metab       Date:  1979-08       Impact factor: 5.958

7.  An acth-secreting pituitary tumour arising in a patient with congenital adrenal hyperplasia.

Authors:  P M Horrocks; S Franks; A D Hockley; E B Rolfe; S Van Noorden; D R London
Journal:  Clin Endocrinol (Oxf)       Date:  1982-11       Impact factor: 3.478

8.  Complement-fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addison's disease.

Authors:  C Betterle; F Zanette; R Zanchetta; B Pedini; A Trevisan; F Mantero; F Rigon
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

9.  Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement.

Authors:  C M Feek; J G Ratcliffe; J Seth; C E Gray; A D Toft; W J Irvine
Journal:  Clin Endocrinol (Oxf)       Date:  1981-05       Impact factor: 3.478

10.  Cushing's disease without hypercortisolism.

Authors:  R N Dexter; D N Orth; K Abe; W E Nicholson; G W Liddle
Journal:  J Clin Endocrinol Metab       Date:  1970-05       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.